Energem Corp. (“Energem”) (Nasdaq: ENCP, ENCPW), a special purpose acquisition company, announced that it has entered into a definitive $200 million Standby Equity Purchase Agreement (“SEPA”) with YA II PN, Ltd., a Cayman Islands exempt limited partnership managed by Yorkville Advisors Global, LP (the “Investor”), and Graphjet Technology Sdn. Bhd., a Malaysian private limited company…

Article originally published by The Hill. Republished with permission from publisher. Authored by Rimon attorney, Amy Baker. Attorneys Mark H. Mirkin, Steven Colby, JD, Ph.D. and David Devernoe contributed to the piece.  The Food and Drug Administration (FDA) considers aging to be a natural process. This makes it difficult to get FDA approval for drugs…

On January 22, 2022, Rimon Partner Mark Mirkin will be serving as a judge in Duke Law School’s Annual Transaction Law Competition, a competition of 54 teams of law students negotiating a contract dispute. The judges are Duke Law School alumni from Ropes & Gray, Akin Gump, King & Spaulding, Sullivan & Cromwell, Paul Weiss,…

Thursday, April 16th • 1 PM ET – (1 CLE Credit ) Learn the ins and outs of the frequently-used convertible debt financing transaction model including a line of credit component for pre-revenue start-ups. You can view the course materials here. Presenter: Mark Mirkin, Mark Mirkin focuses his practice on strategic corporate and securities counseling to emerging and…

Welcome to Rimon’s Complimentary Annual CLE Webinar Series which will be held each Tuesday and Thursday at 1 pm ET. Each course is presented by a Rimon Partner with extensive subject-matter experience. CLE credits: These programs are approved by the CA State Bar for 1 hour of CLE credit for each course. NY bar members are…

Rimon Partner Mark Mirkin will be speaking at The Environmental Mutagenesis & Genomics Society’s 48th Annual Meeting: Environmental Health Sciences Bridging the Gap between Exposure, Mechanism and Public Health. Mr. Mirkin will present at a workshop titled Entrepreneurship, Economic Initiatives and Bioscience Incubators. His discussion of the business perspective of how to start a life science company will…

To expand its legal services to its technology, finance, and higher-education clients, Rimon is proud to announce the opening of its newest office in the Research Triangle region of North Carolina. Rimon, which currently has 17 offices, keeps sustaining a steady growth. Eleven attorneys joined the firm in 2016, and thus far eight partners have joined in…

The Deal: Rimon Partner Mark Mirkin represented the compensation committee of Dyadic International Inc.’s board of directors as the Jupiter-based company prepared to sell its industrial technology business to DuPont for $75 million in cash. Shareholders approved the sale Dec. 11, and the deal closed Dec. 31. Details: The sale of most of its business…

So how do biotech ventures govern themselves to run efficiently while complying with state corporate law statutes and state and federal securities laws and regulations imposed by stock exchanges? Frugality that is often self-imposed by scientific founders and then endorsed by the angel investors and venture capital company investors that follow sequentially tend to result…

The public securities markets and the underwriters that lead biotech companies into them dictate a common capital structure suitable for IPOs, which structure almost always deviates starkly from the capital structure of the venture at inception and during its growth phase. Startups frequently commence corporate life structured as limited liability companies with a few founders…